Predict your next investment

Corporation
HEALTHCARE | Drug Discovery
lakepharma.com

See what CB Insights has to offer

Stage

Acquired | Acquired

Total Raised

$30M

About LakePharma

LakePharma is a contract research organization (CRO) specializing in antibody engineering, antibody discovery, molecular engineering, protein chemistry, bioexpression, biofunction, bioprocessing, and bioanalytics. LakePharma focuses on integrated platforms to support projects throughout the drug discovery process. LakePharma offers dedicated client services and sophisticated software to provide real-time access to project data via a secure cloud-based portal, Datasystems.On July 14th, 2021, LakePharma was acquired by Curia. Terms of the transaction were not disclosed.

LakePharma Headquarter Location

520 Harbor Blvd.

Belmont, California, 94002,

United States

650-288-4891

Latest LakePharma News

Curia completes LakePharma acquisition

Sep 3, 2021

Pharmaceutical Processing World September 3, 2021 Curia , formerly known as AMRI, recently announced that it has completed its acquisition of LakePharma, a biologics drug discovery, clinical research, development and manufacturing organization. The financial terms of the deal were not disclosed. LakePharma has operations in California, Massachusetts and Texas. The acquisition will enable Albany, N.Y.–based Curia to offer expertise in both large and small molecules from drug discovery through drug substance manufacturing, sterile injectable formulation and fill-finish production, according to the company. “The completion of LakePharma transforms our biologics offering, enabling us to provide end-to-end capabilities to customers, based on deep scientific expertise and an integrated technology platform,” Curia chair and CEO John Ratliff said in a September 2 news release. “Together with Integrity Bio, now part of Curia, this transaction represents a major milestone in our growth journey and means we can deliver seamless solutions and expanded capacity for biologics customers,” Ratliff said. LakePharma will operate as part of Curia’s Research and Development division, led by Christopher Conway, president of R&D. LakePharma’s founder and previous CEO Hua Tu will continue as LakePharma’s chief technology officer. LakePharma and its “The Biologics Company” brand will migrate to the Curia brand in the future.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing LakePharma

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

LakePharma is included in 3 Expert Collections, including Pharma Startups.

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

B

Biopharmaceuticals

5,880 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

I

Infectious Disease

2,226 items

Entities aiding the surveillance, screening, prevention, diagnosis, treatment, and containment of infections & the maintenance of public wellbeing during outbreaks.

LakePharma Patents

LakePharma has filed 1 patent.

The 3 most popular patent topics include:

  • Cancer
  • Immune system
  • Immunology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/15/2019

Monoclonal antibodies, Oncology, Immunology, Immune system, Cancer

Application

Application Date

1/15/2019

Grant Date

Title

Related Topics

Monoclonal antibodies, Oncology, Immunology, Immune system, Cancer

Status

Application

LakePharma Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

LakePharma Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.